Contributor

Prof. Dr. Cesare Sirtori

Professor of Clinical Pharmacology at the University of Milan (Italy). Cesare Sirtori was awarded a medical degree at the University of Milan and developed his career in Clinical Pharmacologist, following his Doctor of Philosophy in Pharmacology at the University of Kansas, USA in 1972.

Professor Sirtori started one of the first Centers for the Study of Metabolic Diseases with high atherosclerosis risk. The University Center for Dyslipidemias, at the Niguarda Ca’ Granda Hospital in Milan, is a leading center for clinical research in the field of lipid disorders and arterial disease.

Prof. Sirtori has been Ordinary Professor of Clinical Pharmacology since 1989. He was also Dean of the Faculty of Pharmacy from 2006 to 2012 and is currently President of the Italian Society of Nutraceutics.

Research by Prof. Sirtori has provided major contributions in the understanding of soy proteins, the major hypocholesterolemic nutraceutical as well as the clinical development of metformin, the most widely used oral antidiabetic.

He has over 600 scientific publications.

Prof. Dr. Cesare Sirtori's articles